The co-founders of Fred Hutch's oncology therapeutics developer include Philip Greenberg who previously helped launch Juno Therapeutics.

The corporate card provider was valued at $2.1bn in a round backed by Stanford University that increased its funding to $380m altogether.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Triumvera, co-founded by McMaster's professor Jonathan Bramson, looks to progress its solid tumour therapeutic candidate.

Paule De Blois has stepped down from commercialisation firm Axelys as she accepts a position as deputy minister.

UC Berkeley spinout SiFive has fetched a $2.5bn valuation in a series F round that pushed its overall financing to more than $350m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Having found itself fighting a resolution from Crystal Amber to remove chairman Harry Rein, Allied Minds is exploring its options for the future.

Texas Medical Center has committed another $50m to its TMC Venture Fund, to be deployed over the next decade, adding to its original commitment of $25m in 2017.